Agenda-setting intelligence, analysis and advice for the global fashion community.
Veradermics Inc., a biopharmaceutical firm focused on hair restoration, raised $256.3 million in an upsized US initial public offering priced above the top of its marketed range.
Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.




